Tradestie Institutional Equity Comparison Engine

SGHT vs VTAK โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SGHT Overall Edge

SGHT Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sight Sciences, Inc. Common Stock (SGHT) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, SGHT trades at N/M Forward P/E with -20.2% operating margin (+25.2% YoY revenue) versus VTAK at N/M Forward P/E and -388.1% operating margin (+380.7% YoY). In options structure, SGHT sits in BREAKOUT (8th %ile IV; Dealer Gamma Walls on Pro) against VTAK sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
SGHT N/M vs VTAK N/M Fwd P/E
Growth & Margin Winner SGHT
Op Margin -20.2% vs -388.1% ยท YoY +25.2% vs +380.7%
Momentum & Technical Winner SGHT
1Y +50.2% vs -94.3% ยท 52W Pos 88% vs 1%
Options & Structure Winner SGHT
BREAKOUT (8th %ile IV) vs UNCLASSIFIED (N/A IV)
SGHT NASDAQ
Sight Sciences, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$10.59
-2.22% 1D
Market Cap $601.9M
1M Return +27.9%
1Y Return +50.21%
Forward P/E N/M
Unified AI Score
35.1 / 100 SELL
Tech 50.0 Fund 32.0 Flow 57.0 Mom 50.0
VTAK NYSE American
Catheter Precision, Inc.
Surgical & Medical Instruments & Apparatus
$0.15
-0.66% 1D
Market Cap $548,639
1M Return -24.76%
1Y Return -94.28%
Forward P/E N/M
Unified AI Score
58.1 / 100 HOLD
Tech 72.0 Fund 70.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SGHT +50.21% VTAK -94.28% Spread: +113.62 pp (SGHT Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SGHT Revenue VTAK Revenue SGHT Op. Margin VTAK Op. Margin Margin Edge
FY2018 N/A $10M N/A -498.0% VTAK
FY2019 N/A $10M N/A -801.9% VTAK
FY2020 $30M $0M -116.5% -13668.3% SGHT
FY2021 $50M $0M -105.2% -133027.3% SGHT
FY2022 $70M $0M -117.7% -192578.6% SGHT
FY2023 $80M $0M -70.7% -17674.0% SGHT
FY2024 $80M $0M -63.3% -2676.9% SGHT
FY2025 $80M $0M -48.0% -2581.6% SGHT

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SGHT (5) vs VTAK (3)
Institutional Metric SGHT VTAK Criterion Row Winner
Market Capitalization Scale $601.9M $548,639 Larger Scale SGHT
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +25.2% +380.7% Higher Growth VTAK
Operating Margin (TTM) Profitability -20.2% -388.1% Higher Margin SGHT
Net Profit Margin Profitability -32.1% 0.0% Higher Margin VTAK
Return on Equity (ROE) Capital Efficiency -50.1% -111.3% Higher ROE SGHT
52-Week Range Position Momentum 88% ($3โ€“$12) 1% ($0โ€“$3) Stronger Trend SGHT
Beta / 30D Volatility Risk Regime 1.05ฮฒ ยท 45% Vol 0.19ฮฒ ยท 76% Vol Lower Realized Risk SGHT
Unified Institutional Score Composite Signal 35.1 / 100 (SELL) 58.1 / 100 (HOLD) Higher Composite VTAK

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SGHT vs VTAK Buy Guide
SGHT BREAKOUT
33d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 8th %ile
IV Regime Compressed (<25th %ile)
Live SGHT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
VTAK UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VTAK Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SGHT nor VTAK registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.